Navigation Links
Few Ontario women with invasive ovarian cancer referred for genetic testing of breast cancer genes
Date:12/4/2008

(TORONTO: December 4, 2008) - An Ontario study of 491 women with invasive ovarian cancer found only a small proportion, 19%, were referred for genetic testing of BRCA1 and BRCA2, the breast cancer genes, which means family members are not informed of their cancer risk.

Dr. Kelly Metcalfe, an associate professor at the University of Toronto's Lawrence S. Bloomberg Faculty of Nursing, and an adjunct scientist at Women's College Research Institute, led the nursing study, which was published online yesterday in the journal, Gynecologic Oncology.

"Although approximately 10% of women with ovarian cancer have a BRCA1 or BRCA2 mutation, the majority of women are not being referred for genetic testing. Women may not know they are eligible for free genetic testing and counseling, or health-care providers may not be making the referrals. This puts an entire family at risk because family members are unaware that they may also be at a very high risk of developing breast or ovarian cancer," says Metcalfe.

According to Metcalfe's study, lack of genetic testing referral for such women will miss more than one-third of those with BRCA1 and BRCA2 mutations. These mutations mean an 80% lifetime risk of breast cancer for these women and for family members who may also carry the gene.

The study also found women were more likely to get tested if they were:

  • White (20.6%)
  • Had children (21.3%)
  • And had a positive family history of breast cancer (47.2%) or ovarian cancer (55.2%), or personal history of breast cancer (62.1%)

In 2001, the Ontario Ministry of Health extended the criteria for genetic testing to include all women with a diagnosis of invasive ovarian or fallopian tube cancer because of the prevalence of the BRCA1 and BRCA2 gene mutations in these women. The purpose of the study was to assess the impact of this expanded policy for genetic testing in Ontario.

Generally, patients rely on physician referral for genetic testing. The study concludes reliance on physicians for patient referrals for genetic testing is inadequate and greater physician education and public awareness is needed.


'/>"/>

Contact: Lucianna Ciccocioppo
lucianna.ciccocioppo@utoronto.ca
416-946-3657
University of Toronto
Source:Eurekalert

Related medicine news :

1. U of T research supports Ontario ban on cigarette displays
2. Spinal cord research heads new $10M funding in London, Ontario
3. Marijuana use on the rise among Ontario adults, CAMH reports
4. HearAtLast Expands Chain to 18 Locations Opening New Clinic in Aurora, Ontario Wal-Mart Store # 5778
5. HearAtLast Expands Chain to 17 Locations, Opening New Clinic in Oshawa, Ontario Wal-Mart Supercenter # 1056
6. Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario
7. HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sams Club in Richmond Hill, Ontario
8. 2007 Ottawa & Eastern Ontario Physique Championship to be Sponsored by Natural Nutrition
9. Women Unhappy With Disposal Options After Infertility Treatment
10. Financial Concerns Top List of Holiday Stressors for Women, Families with Children
11. PAHEF Works to Prevent Violence Against Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... On June ... sponsor of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, ... of the city’s history as home to some of the world’s leading providers of ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced traumatic events may suffer ... unhealthy avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid ... healthy coping following a traumatic event. , Trauma sufferers tend to feel a range ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
Breaking Medicine Technology: